Personalis, Inc.

PSNL Healthcare Diagnostics & Research

Personalis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $69.6 million, down 17.7% from fiscal 2024. In the quarter to June 2026, revenue grew 30.0%, EPS fell 30.4% and free cash flow fell 123.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

15.65 0.28 −1.76%
Market cap
$1.7B
P/E
0.0×
Fwd P/E
−10.5×
Dividend yield
—
F-score
4/9
Altman Z
3.35
Beneish M
−1.30
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
8.37 10.20 10.29 20.28
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(26.52) (31.93) (29.53) (54.82)
P/B ratio
3.37 2.72 2.61 6.01
Price to Tangible BV
3.37 2.72 2.61 6.01
EV/Sales
6.45 7.01 6.95 17.48
EV/EBITDA
0.00 0.00 0.00 0.00
EV/Operating CF
(7.37) (6.52) (5.64) (13.20)
EV/FCF
(6.74) (6.15) (5.31) (12.08)
Quick Ratio
4.56 6.46 6.31 4.91
Current Ratio
4.82 6.76 6.61 5.28
Net Debt/EBITDA
6.91 10.15 7.54 6.60
Debt/Assets
0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00
Asset Turnover
0.29 0.23 0.22 0.24
Operating CF/Net income
1.01 0.93 0.75 0.81
Capex/Depreciation
(1.07) (0.05) (2.47) (2.81)
Interest Coverage
(363.92) (388.71) (684.28) (907.86)
Research and Development Expense of Revenue
83.97% 75.36% 93.97% 73.07%
Selling, General and Administrative Expense of Revenue
89.92% 81.26% 115.71% 98.39%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
14.36% 13.25% 16.50% 17.81%
Graham Net Nets
0.18 0.27 0.28 0.12
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(13.50%) (11.43%) (16.01%) (8.13%)
Free Cash Flow Yield
(11.44%) (11.18%) (12.74%) (7.14%)
Revenue per Share
0.16 0.19 0.15 0.21
Operating CF per Share
(0.25) (0.25) (0.22) (0.24)
Capex per Share
(0.02) 0.00 (0.03) (0.04)
Free Cash Flow per Share
(0.26) (0.25) (0.25) (0.28)
Cash per Share
1.70 2.69 2.24 2.02
Shareholders Equity per Share
1.93 2.93 2.45 2.23
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
1.93 2.93 2.45 2.23
Free Cash Flow
(23.43) (22.32) (25.55) (29.55)
Working Capital
138.25 228.32 219.15 198.67
Capital Expenditures
(1.63) (0.08) (3.07) (3.78)
Net Current Asset Value
102.98 194.97 187.57 168.08
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.11 0.00 0.20 0.17
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
13.93 12.17 12.00 12.53
Average Payables
11.80 9.69 10.30 12.97
Average Inventory
6.57 6.04 5.93 7.54
Average Assets
241.36 302.22 299.35 285.41
Average Common Equity
169.09 232.07 231.06 213.00

Fold the line items

Columns are period end dates